Natural surfactant combined with beclomethasone decreases lung inflammation in the preterm lamb

Respiration

Volumn 82, Issue 4, 2011, Pages 369-376

  Dani, Carlo ^a   Corsini, Iuri ^a   Burchielli, Silvia ^b   Cangiamila, Valentina ^c   Romagnoli, Roberta ^d   Jayonta, Bhattacharjee ^d   Longini, Mariangela ^d   Paternostro, Ferdinando ^e   Buonocore, Giuseppe ^b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Beclomethasone; Glucocorticoid; Inflammation; Lung injury; Preterm lamb; Surfactant

Indexed keywords

BECLOMETASONE; BECLOMETASONE DIPROPIONATE; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR; PORACTANT; SURFACTANT;

AIRWAY PRESSURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHIAL ASPIRATION PROCEDURE; CONTROLLED STUDY; HYPOTHESIS; LUNG COMPLIANCE; LUNG MECHANICS; NEUTROPHIL COUNT; NONHUMAN; PNEUMONIA; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS; BECLOMETHASONE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFANT, NEWBORN; INTERLEUKIN-8; MACROPHAGE MIGRATION-INHIBITORY FACTORS; OXIDATIVE STRESS; PNEUMONIA; PREGNANCY; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SHEEP;

EID: 80052986333     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000328928     Document Type: Article

References (40)

1. Hayes D Jr, Feola DJ, Murphy BS, Shook LA, Ballard HO: Pathogenesis of bronchopulmonary dysplasia. Respiration 2010;79:425-436.
2. Bose CL, Dammann CE, Laughon MM: Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed 2008;93:F455-F461.
3. Ogden B, Murphy SA, Saunders G, Pathak D, Johnson D: Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 1984;130:817-821. (Pubitemid 15209566)
4. Groneck P, Gotze-Speer B, Oppermann M, Eiffert H, Speer CP: Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dyspla sia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 1994;93:712-718. (Pubitemid 24136101)
5. Horowitz S, Shapiro DL, Finkelstein JN, Notter RH, Johnston CJ, Quible DJ: Changes in gene expression in hyperoxia induced neonatal lung injury. Am J Physiol 1990;258:L107-L111. (Pubitemid 20096797)
6. Schock BC, Sweet DG, Ennis M, Warner JA, Young IS, Halliday HL: Oxidative stress and increased type-IV collagenase levels in bronchoalveolar lavage fluid from newborn babies. Pediatr Res 2001;50:29-33. (Pubitemid 32566570)
7. Finck CM, Hodell MG, Marx WH, Paskanik AM, McGraw DJ, Lutz CJ, Gatto LA, Picone AL, Nieman GF: Endotoxin-stimulated alveolar macrophage recruitment of neutrophils and modulation with exogenous surfactant. Crit Care Med 1998;26:1414-1418. (Pubitemid 28384643)
8. Miles PR, Bowman L, Rao KM, Baatz JE, Huffman L: Pulmonary surfactant inhibits LPS-induced nitric oxide production by alveolar macrophages. Am J Physiol 1999;276:L186-L196. (Pubitemid 29061680)
9. Hayakawa H, Giridhar G, Myrvik QN, Kucera L: Pulmonary surfactant phospholipids modulate priming of rabbit alveolar macrophages for oxidative responses. J Leukoc Biol 1992;51:379-385.
10. Kerecman J, Mustafa SB, Vasquez MM, Dixon PS, Castro R: Immunosuppressive properties of surfactant in alveolar macrophage NR8383. Inf lamm Res 2008;57:118-125. (Pubitemid 351457939)
11. Sadowska AM, Klebe B, Germonpre P, De Backer WA: Glucocorticosteroids as antioxidants in treatment of asthma and COPD. New application for an old medication? Steroids 2007;72:1-6. (Pubitemid 46037762)
12. Frank L, Lewis PL, Sosenko IR: Dexamethasone stimulation of fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation. Pediatrics 1985;75:569-574. (Pubitemid 15144676)
13. Walther FJ, David-Cu R, Mehta EI, Polk DH, Jobe AH, Ikegami M: Higher lung antioxidant enzyme activity persists after single dose of corticosteroids in preterm lambs. Am J Physiol 1996;271:L187-L191.
14. Chandrasekar I, Eis A, Konduri GG: Betamethasone attenuates oxidant stress in endothelial cells from fetal lambs with persistent pulmonary hypertension. Pediatr Res 2008;63:67-72.
15. Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DK 3rd, Gluck L: Elastase and alpha-1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest 1983;72:656-666.
16. Dani C, Corsini I, Burchielli S, Cangiamila V, Longini M, Paternostro F, Buonocore G, Rubaltelli FF: Natural surfactant combined with beclomethasone decreases oxidative lung injury in the preterm lamb. Pediatr Pulmonol 2009;44:1159-1167.
17. Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, Hartwell D, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M: Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta-2 agonists for the treatment of chronic asthma in children under the age of 12 years. Health Technol Assess 2008;12:1-174.
18. De Dooy JJ, Mahieu LM, van Bever HP: The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr 2001;160:457-463. (Pubitemid 32695823)
19. Thomas W, Seidenspinner S, Kawczynska-Leda N, Kramer BW, Chmielnicka-Kopaczyk M, Marx A, Szymankiewicz M, Speer CP: Systemic fetal inflammation and reduced concentrations of macrophage migration inhibitory factor in tracheobronchial aspirate fluid of extremely premature infants. Am J Obstet Gy necol 2008;198:64.e1-e6.
20. Kevill KA, Bhandari V, Kettunen M, Leng L, Fan J, Mizue Y, Dzuira JD, Reyes-Mugica M, McDonald CL, Baugh JA, O'Connor CL, Aghai ZH, Donnelly SC, Bazzy-Asaad A, Bucala RJ: A role for macrophage migration inhibitory factor in the neonatal respiratory distress sy ndrome. J Immunol 2008;180:601-608.
21. Ietta F, Todros T, Ticconi C, Piccoli E, Zicari A, Piccione E, Pau lesu L: Macrophage migr ation inhibitory factor in human pregnancy and labor. Am J Reprod Immunol 2002;48:404-409. (Pubitemid 35469292)
22. Mukaida N: Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol 2003;284:L566-L577. (Pubitemid 36343304)
23. Baier RJ, Loggins J, Kruger TE: Monocyte chemoattractant protein-1 and interleukin-8 are increased in bronchopulmonary dysplasia: relation to isolation of Ureaplasma urealyticum. J Investig Med 2001;49:362-369. (Pubitemid 33009528)
24. Vento G, Capoluongo E, Matassa PG, Concolino P, Vendettuoli V, Vaccarella C, Frezza S, Zuppi C, Romagnoli C, Ameglio F: Serum levels of seven cytokines in premature ventilated newborns: correlations with old and new forms of bronchopulmonary dysplasia. Intensive Care Med 2006;32:723-730.
25. Liu DY, Wu J, Zhang XY, Feng ZC: Expression of IL-8, SP-A and TGF-beta1 in bronchoalveolar lavage fluid of neonates with bronchopulmonary dysplasia. Zhongguo Dang Dai Er Ke Za Zhi 2010;12:444-446.
26. Abate W, Alghaithy AA, Parton J, Jones KP, Jackson SK: Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains. J Lipid Res 2010;51:334-344.
27. Groneck P, Goetze-Speer B, Speer CP: Effects of inhaled beclomethasone compared to systemic dexamethasone on lung inflammation in preterm infants at risk of chronic lung disease. Pediatr Pulmonol 1999;27:383-387. (Pubitemid 29265020)
28. Irakam A, Miskolci V, Vancurova I, Davidson D: Dose-related inhibition of proinflammatory cytokine release from neutrophils of the newborn by dexamethasone, betamethasone, and hydrocortisone. Biol Neonate 2002;82:89-95.
29. Schultz C, Rott C, Temming P, Schlenke P, Möller JC, Bucsky P: Enhanced interleukin-6 and interleukin-8 synthesis in term and preterm infants. Pediatr Res 2002;51:317-322. (Pubitemid 34174967)
30. Calandra T, Roger T: Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003;3:791-800. (Pubitemid 37328657)
31. Korsgren M, Källström L, Uller L, Bjerke T, Sundler F, Persson CG, Korsgren O: Role of macrophage migration inhibitory factor (MIF) in allergic and endotoxin-induced airway inflammation in mice. Mediators Inf lamm 2000;9:15-23. (Pubitemid 30399113)
32. Baugh JA, Donnelly SC: Macrophage migration inhibitory factor: a neuroendocrine modulator of chronic inflammation. J Endocrinol 2003;179:15-23. (Pubitemid 37321563)
33. Ikegami M, Carter K, Bishop K, Yadav A, Masterjohn E, Brondyk W, Scheule RK, Whitsett JA: Intratracheal recombinant surfactant protein d prevents endotoxin shock in the newborn preterm lamb. Am J Respir Crit Care Med 2006;173:1342-1347. (Pubitemid 43900708)
34. Mokra D, Mokry J, Drgova A, Petraskova M, Bulokova J, Calkosvka A: Intratracheally administered corticosteroids improve lung function in meconium-instilled rabbits. J Physiol Pharmacol 2007;58:389-398. (Pubitemid 351346688)
35. Wang J, Winskog C, Edston E, Walther SM: Inhaled and intravenous corticosteroids both attenuate chlorine gas-induced lung injury in pigs. Acta Anaesthesiol Scand 2005;49:183-190. (Pubitemid 40313230)
36. LaForce WR, Brudno DS: Controlled trial of beclomethasone dipropionate by nebulization in oxygen-and ventilator-dependent infants. J Pediatr 1993;122:285-288. (Pubitemid 23041562)
37. Chen CM, Fang CL, Chang CH: Surfactant and corticosteroid effects on lung function in a rat model of acute lung injury. Crit Care Med 2001;29:2169-2175.
38. Shah SS, Ohlsson A, Halliday H, Shah VS: Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight neonates. Cochrane Database Syst Rev 2007;17:CD002057.
39. Nimmo AJ, Carstairs JR, Patole SK, Whitehall J, Davidson K, Vin k R: Intratracheal administration of glucocorticoids using surfactant as a vehicle. Clin Exp Pharmacol Physiol 2002;29:661-665. (Pubitemid 34779615)
40. Derendorf H, Meltzer EO: Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy 2008;63:1292-1300.